Top Markets
Coin of the day
Predilife S.A. Predilife S.A.

Predilife S.A.

ALPRE
株式のランク #18209
Predilife S.A. develops and sells medical techniques and mathematical models.... Predilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient's individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device for the prediction of prostate cancer risk. Predilife S.A. was founded in 2004 and is headquartered in Villejuif, France.
株価
$1.71
時価総額
$6.73M
変化(1日)
-4.00%
変化(1年)
-61.64%
FR
取引 Predilife S.A. (ALPRE)

カテゴリー

Predilife S.A.(ALPRE)の収益
Dec 2025 時点の収益 TTM: $1.31M
Predilife S.A. の最新の財務報告によると、現在の収益 (TTM) は $1.31M です。2023 年には $351.31K の収益があり、これは 2022 年の $309.58K と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Predilife S.A. の収益履歴(2016 ~ 2026)
各年末の収益
収益 変化
2026 (TTM) $1.31M 103.93%
2024 $643.13K 83.07%
2023 $351.31K 13.48%
2022 $309.58K 91.60%
2021 $161.57K 157.25%
2020 $62.81K 144.75%
2019 $25.66K -69.09%
2018 $83.04K 64.75%
2017 $50.40K 598,648.91%
2016 $8.42 0.00%
同業他社の収益
企業 収益 収益の差
$45.20B 3,446,019.39%
US
$24.78B 1,889,139.25%
US
$6.99B 532,702.35%
CN
$4.45B 338,899.80%
US
$2.50B 190,587.28%
US